Open the mobile version, with barcode scanning
Class III Ongoing

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Company
Chiesi USA, Inc.
Cary, NC, United States
Reported
Sep 9, 2026
Recall started
Aug 19, 2026
Where sold
MO, TN
Amount
3,002 vials
Full product description
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
Lots / codes affected
Lot#: 1221973, Exp 3/24/2027

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.